How human cells control the machine that makes RNA
Mechanisms of RNA polymerase II transcription regulation
Researchers are looking at how the molecular machinery in human cells starts and controls copying genes into RNA to better understand conditions like cancer and heart disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-11266454 on NIH RePORTER |
What this research studies
This project rebuilds the human RNA polymerase II machinery from purified parts and tests how it works using lab-grown human cells and biochemical assays. Scientists will study the Pre-Initiation Complex and partner proteins to see how they start transcription, pause, and stop, and how structures like phase-separated condensates affect activity. The team combines detailed molecular experiments with cell-based tests to link basic mechanisms to gene expression patterns seen in cancer and cardiac disease. Findings are intended to clarify how abnormal gene control could lead to disease and point to future targets for therapy.
Who could benefit from this research
Good fit: This grant does not enroll patients; the work uses purified components and human cell models rather than patient volunteers.
Not a fit: Patients should not expect direct clinical benefit or access to new treatments from this basic laboratory research.
Why it matters
Potential benefit: If successful, this work could reveal molecular targets to correct abnormal gene activity in cancers and heart disease.
How similar studies have performed: Previous laboratory studies of transcription machinery have uncovered important gene-regulation principles, but translating those discoveries into therapies remains early and uncertain.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Taatjes, Dylan J — University of Colorado
- Study coordinator: Taatjes, Dylan J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.